论药品专利保护与药品可及性之间的矛盾——以公共健康危机为视角  

Study on the Contradiction between the Protection of Pharmaceutical Patent and Drug Access——From the Perspective of Public Health Crisis

作　　者：邢爽[1] 刘兰茹[1] 刘培伟[1] 朱虹[1] 

机构地区：[1]哈尔滨医科大学

出　　处：《医学与法学》2013年第6期39-42,共4页Medicine and Jurisprudence

基　　金：四川医事卫生法治研究中心立项资助项目"基本药物可获得性的制度建设研究"(课题编号:YF11Z03);黑龙江省哲学社会科学研究规划项目"黑龙江省高新技术产业--医药科技创新与知识产权联动研究"(课题编号:10B053)的阶段性成果

摘　　要：在公共健康危机频频爆发的社会环境下,药品专利保护与药品可及性之间的矛盾也日益凸显。本文在浅谈我国目前药品可及性现状以及药品可及性对维护和发展公共健康的意义的基础上,站在公共健康危机的角度,对药品专利保护与药品可及性之间的矛盾进行了分析,并浅析几种解决此矛盾的途径,期待能为该矛盾的妥善解决提供思路。Under the social environment of frequent outbreaking of public health crisis, the contradiction between the protection of pharmaceutical patent and drug access have become increasingly prominent. Therefore, based on the current status of Chinese drug access and the significance of drug access to maintain and develop public health, this paper analyzes the contradiction between the protection of pharmaceutical patent and drug access, and the ways to resolve the contradiction from the perspective of public health crisis, expecting the proper solution to the contradiction.

关 键 词：药品专利保护 公共健康 药品可及性 

分 类 号：R95[医药卫生—药学]